Xenetic Biosciences Inc (XBIO)

Overview News Price History Financials Discussions Forecast Stock Split

Xenetic Biosciences Inc Stock (XBIO) Financials Data

*All numbers in millions

Period End Date	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	23.98% 0.5108	0.672	0.6112	0.651	0.6058
Operating Expenses	7.70% 1.7792	1.9276	1.7579	1.8492	1.521
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	7.70% 1.7792	1.9276	1.7579	1.8492	1.521
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	1.02% -1.2684	-1.2557	-1.1467	-1.1982	-0.9152
Net Interest Income/Expense	12.55% 0.0732	0.0838	0.0918	0.1261	0.0541
Nonoperating Income/Loss	12.90% 0.0733	0.0842	0.0911	0.1472	0.0586
Income/Loss From Continuing Operations Before Tax	23.98% 0.5108	0.672	0.6112	0.651	0.6058
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	2.02% -1.1951	-1.1715	-1.0556	-1.051	-0.8566
Net Income/Loss	2.02% -1.1951	-1.1715	-1.0556	-1.051	-0.8566
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	44,008% 1.5407	0.00349	1.5326	1.5247	15.17
Diluted Average Shares	44,008% 1.5407	0.00349	1.5326	1.5247	15.17
Basic Earnings Per Share	1.30% -0.78	-0.77	-0.69	-0.69	-0.06
Diluted Earnings Per Share	1.30% -0.78	-0.77	-0.69	-0.69	-0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

GMAB

$21.50

1.61%

INCY

$74.59

1.14%

UTHR

$370.49

2.02%

MRNA

$43.06

0.76%

BGNE

$215.00

4.29%

BNTX

$118.39

1.93%